Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹302 Cr
up ₹15.6 Cr vs May 2024
- Stocks held
- 19
- up 1 vs May 2024
- Top 10 weight
- 70.6%
- of the portfolio in its ten largest
- Cash & debt
- 2.6%
- cash, money market and debt
- Moves this month
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In June 2024 it disclosed 19 stocks worth ₹302 Cr, up ₹15.6 Cr from May 2024. Its largest positions were Poly Medicure Limited (9.5%), GlaxoSmithKline Pharmaceuticals Limited (8.9%), Aurobindo Pharma Limited (8.7%); the ten largest together made up 70.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 71.0% of its equity. Cash and debt stood at 2.6%. Compared with May 2024 the fund entered 2 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
5%
Holds more stocks than 5% of peers
Cash
36%
Holds more cash than 36% of peers
What these mean: concentration · cash
Holdings in June 2024
Download CSVEvery line the fund disclosed, with the change against May 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Poly Medicure Limited | 9.50% | up 0.15 pts | ₹28.7 Cr | up ₹1.9 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 8.85% | down 0.37 pts | ₹26.8 Cr | up ₹32 L | Added |
| Aurobindo Pharma Limited | 8.68% | down 0.31 pts | ₹26.2 Cr | up ₹48 L | Added |
| Pfizer Limited | 8.14% | down 0.60 pts | ₹24.6 Cr | down ₹44 L | Trimmed |
| Zydus Lifesciences Limited | 6.92% | up 0.12 pts | ₹20.9 Cr | up ₹1.4 Cr | Added |
| Dr. Reddy's Laboratories Limited | 6.91% | up 1.86 pts | ₹20.9 Cr | up ₹6.4 Cr | Added |
| Aarti Pharmalabs Limited | 5.67% | up 0.17 pts | ₹17.2 Cr | up ₹1.4 Cr | Added |
| Kovai Medical Center and Hospital Limited | 5.59% | down 0.18 pts | ₹16.9 Cr | up ₹36 L | Added |
| Indraprastha Medical Corporation Limited | 5.28% | down 0.48 pts | ₹16 Cr | down ₹54 L | Trimmed |
| Gujarat Themis Biosyn Ltd | 5.04% | up 0.75 pts | ₹15.2 Cr | up ₹2.9 Cr | Added |
| SMS Pharmaceuticals Limited | 4.44% | up 0.29 pts | ₹13.4 Cr | up ₹1.5 Cr | Added |
| Aster DM Healthcare Limited | 4.02% | up 2.93 pts | ₹12.2 Cr | up ₹9 Cr | Added |
| Sequent Scientific Limited | 3.75% | up 0.25 pts | ₹11.3 Cr | up ₹1.3 Cr | Added |
| Granules India Limited | 3.42% | up 0.36 pts | ₹10.3 Cr | up ₹1.6 Cr | Added |
| Suven Life Sciences Limited | 2.89% | up 0.21 pts | ₹8.7 Cr | up ₹1 Cr | Added |
| Sanofi India Limited | 2.55% | up 2.55 pts | ₹7.7 Cr | up ₹7.7 Cr | New |
| AstraZeneca Pharma India Limited | 2.40% | down 0.10 pts | ₹7.3 Cr | up ₹8 L | Added |
| 91 Days Treasury Bill 15-Aug-2024 Debt | 1.64% | down 0.08 pts | ₹5 Cr | up ₹3 L | Added |
| BROOKS Laboratories Limited | 1.39% | up 0.03 pts | ₹4.2 Cr | up ₹30 L | Added |
| Cash, TREPS & receivables | 1.01% | down 0.82 pts | ₹3 Cr | down ₹2.2 Cr | Trimmed |
| Sanofi Consumer Healthcare India Limited | 0.99% | up 0.99 pts | ₹3 Cr | up ₹3 Cr | New |
| SBI Life Insurance Company Limited 25/07/2024 Derivative | 0.93% | up 0.93 pts | ₹2.8 Cr | up ₹2.8 Cr | New |
What changed, May 2024 to Jun 2024
New New positions (2)
- Sanofi India Limited2.5% · ₹7.7 Cr
- Sanofi Consumer Healthcare India Limited1.0% · ₹3 Cr
Exited Exited (1)
- Life Insurance Corporation Of Indiawas 8.7% · ₹24.8 Cr
Added Biggest additions
- Aster DM Healthcare Limitedup ₹9 Cr (+2.93% pts)
- Dr. Reddy's Laboratories Limitedup ₹6.4 Cr (+1.86% pts)
- Gujarat Themis Biosyn Ltd
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2024, the weight rose most in Pharmaceuticals & Biotechnology (+6.0 pts) and Healthcare Services (+2.8 pts), and fell most in Insurance (−9.1 pts).
- Pharmaceuticals & Biotechnology65.0% → 71.0%+6.0 pts
- Healthcare Services16.1% → 18.9%+2.8 pts
- Healthcare Equipment & Supplies9.8% → 10.1%+0.3 pts
- Insurance9.1% → 0.0%exited−9.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Dec 2023 | Mar 2024 | May 2024 | Jun 2024 |
|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 53.5% | 44.7% | 65.0% | 71.0% |
| Healthcare Services | 12.2% | 15.5% | 16.1% | 18.9% |
| Healthcare Equipment & Supplies | — | 9.8% | 9.8% | 10.1% |
Allocation in Jun 2024change vs May 2024
- Pharmaceuticals & Biotechnology (12)71.0%▲ 6.0 pts
- Healthcare Services (4)18.9%▲ 2.8 pts
- Healthcare Equipment & Supplies (1)10.1%▲ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2024
2.6%
▼ 0.9 pts vs May 2024
- Cash alone
- 1.0%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.5% – 7.5%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.